Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M23,628Revenue (TTM) $M9,749Net Margin (%)8.3Altman Z-Score2.2
Enterprise Value $M29,904EPS (TTM) $1.6Operating Margin %14.4Piotroski F-Score5
P/E(ttm)29.8Beneish M-Score-2.5Pre-tax Margin (%)9.0Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %13.1Quick Ratio1.1Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %7.5Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow16.2y-y EBITDA Growth Rate %2.7ROA % (ttm)3.6Higher Current Ratio y-yY
Dividend Yield %--PEG4.0ROE % (ttm)8.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M508ROIC % (ttm)7.7Gross Margin Increase y-yN

Gurus Latest Trades with MYL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYLDavid Tepper 2016-03-31 Sold Out -0.92%$41.42 - $54.09
($48.28)
$ 46.48-4%Sold Out0
MYLJoel Greenblatt 2016-03-31 Add0.44%$41.42 - $54.09
($48.28)
$ 46.48-4%Add 9178.19%837,728
MYLVanguard Health Care Fund 2016-03-31 Add0.25%$41.42 - $54.09
($48.28)
$ 46.48-4%Add 10.00%26,679,385
MYLJohn Paulson 2016-03-31 Add0.19%$41.42 - $54.09
($48.28)
$ 46.48-4%Add 2.38%23,335,861
MYLJohn Keeley 2016-03-31 Sold Out -0.09%$41.42 - $54.09
($48.28)
$ 46.48-4%Sold Out0
MYLMario Gabelli 2016-03-31 Reduce$41.42 - $54.09
($48.28)
$ 46.48-4%Reduce -35.73%17,000
MYLDavid Einhorn 2015-12-31 Buy 2.86%$39.16 - $55.28
($48.35)
$ 46.48-4%New holding2,890,000
MYLDavid Tepper 2015-12-31 Add0.41%$39.16 - $55.28
($48.35)
$ 46.48-4%Add 81.62%853,749
MYLJohn Paulson 2015-12-31 Add0.29%$39.16 - $55.28
($48.35)
$ 46.48-4%Add 4.02%22,794,061
MYLVanguard Health Care Fund 2015-12-31 Add0.11%$39.16 - $55.28
($48.35)
$ 46.48-4%Add 4.26%24,253,075
MYLMario Gabelli 2015-12-31 Reduce-0.01%$39.16 - $55.28
($48.35)
$ 46.48-4%Reduce -60.67%26,450
MYLJoel Greenblatt 2015-12-31 Buy 0.01%$39.16 - $55.28
($48.35)
$ 46.48-4%New holding9,029
MYLJohn Keeley 2015-12-31 Reduce$39.16 - $55.28
($48.35)
$ 46.48-4%Reduce -8.09%51,580
MYLDavid Tepper 2015-09-30 Reduce-0.87%$39.8 - $71.49
($55.75)
$ 46.48-17%Reduce -52.50%470,071
MYLVanguard Health Care Fund 2015-09-30 Add0.64%$39.8 - $71.49
($55.75)
$ 46.48-17%Add 46.38%23,262,875
MYLJohn Keeley 2015-09-30 Add0.02%$39.8 - $71.49
($55.75)
$ 46.48-17%Add 51.47%56,120
MYLMario Gabelli 2015-09-30 Add0.01%$39.8 - $71.49
($55.75)
$ 46.48-17%Add 102.26%67,250
MYLJohn Paulson 2015-06-30 Add2.24%$57.94 - $76.06
($70.49)
$ 46.48-34%Add 46.59%21,913,061
MYLDavid Tepper 2015-06-30 Buy 1.66%$57.94 - $76.06
($70.49)
$ 46.48-34%New holding989,528
MYLFirst Eagle Investment 2015-06-30 Sold Out -0.08%$57.94 - $76.06
($70.29)
$ 46.48-34%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MAROON JOSEPH C MDDirector 2016-06-03Buy1,670$44.953.4view
MAROON JOSEPH C MDDirector 2016-05-25Buy2,370$42.479.44view
Cindrich Robert JDirector 2016-05-25Buy1,190$42.479.44view
HIGGINS MELINA EDirector 2016-05-12Buy19,900$38.6820.17view
HIGGINS MELINA EDirector 2016-05-06Buy100$38.6920.13view
HIGGINS MELINA EDirector 2016-04-28Buy35,000$42.928.29view
COURY ROBERT JExecutive Chairman 2016-04-05Sell217,755$45.961.13view
MAROON JOSEPH C MDDirector 2016-03-31Buy4,337$46.360.26view
PARRISH MARK WDirector 2016-03-17Buy1,705$445.64view
CAMERON WENDYDirector 2016-03-08Buy2,190$45.691.73view

Press Releases about MYL :

Quarterly/Annual Reports about MYL:

News about MYL:

Articles On GuruFocus.com
10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate? Jul 01 2016 
Growing Generic Drug Market a Good Opportuity for 2 India Firms May 30 2016 
Samuel Isaly Trades in Health Care Stocks in 1st Quarter Apr 27 2016 
John Keeley Comments on Mylan Labs Apr 26 2016 
Ackman to Testify About Valeant Before Senate Apr 26 2016 
Mawer's Investment Newsletter 1st Quarter Apr 15 2016 
Insiders Keep on Selling Facebook and Ford Apr 08 2016 
Buy Perrigo After a Big Selloff? Yes Apr 04 2016 
David Einhorn's Top 5 New Q4 Buys Feb 16 2016 
David Einhorn Rebounds – Somewhat Feb 09 2016 

More From Other Websites
Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say Jul 26 2016
Why these traders are buying puts in Mylan Jul 26 2016
Mylan’s EpiPen price increases are Valeant-like in size, Shkreli-like in approach Jul 23 2016
EU watchdog flags faulty generic drug data, backs sales halt Jul 22 2016
Mylan Publishes Supplement to Meda Offer Document Jul 21 2016
Mylan And Biocon Says EMA Accept Its Regulatory Submission Of Biosimilar Pegfilgrastim Jul 21 2016
Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for... Jul 21 2016
[$$] Business Watch Jul 20 2016
Mylan Gets EC Clearance for Meda Purchase Jul 20 2016
Mylan Launches Generic Crestor® Tablets Jul 20 2016
Mylan gets EU approval for Meda purchase, subject to conditions Jul 20 2016
Mylan gets EU approval for Meda purchase, subject to conditions Jul 20 2016
Judge refuses to block generic versions of AstraZeneca's Crestor Jul 19 2016
Mylan Is Poised to Break Sideways Trend Jul 19 2016
The Zacks Analyst Blog Highlights: Manulife Financial, Mylan, Huntsman, Air Lease and Bofi Holding Jul 18 2016
6 Stocks Still Trading Cheap in Today's Market Jul 15 2016
Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources Jul 15 2016
These Four Drugs Were Withdrawn by the CHMP in June Jul 12 2016
UBS Quality Growth at a Reasonable Price Stocks Crush the S&P 500: 3 to Buy Right Now Jul 12 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)